Joseph Talamo
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2020-08-21
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | $374,696 | $723,739 |
| 2024 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | $370,000 | $1,662,576 |
| 2023 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | $14,231 | $456,371 |
| 2022 | Intensity Therapeutics, Inc. (INTS) | Chief Financial Officer | — | — |
| 2020 | Lisata Therapeutics, Inc. (LSTA) | Former Chief Financial Officer | $223,388 | $495,138 |
| 2019 | Lisata Therapeutics, Inc. (LSTA) | Former Chief Financial Officer | $338,077 | $676,630 |
| 2018 | Lisata Therapeutics, Inc. (LSTA) | Chief Financial Officer | $334,673 | $834,955 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.